Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

"The size is significant. We're talking about 900 million patients that could benefit from Mounjaro," Montarce said at the Leerink Partners Global Healthcare Conference. Global demand for Lilly's and ...

Lilly plans to build four new pharmaceutical plants in the US, creating 13,000 jobs and bringing its recent domestic ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

The pharmaceutical firm is growing its presence across three states, creating 3,000 jobs.

Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.

Eli Lilly has announced plans to expand its domestic medicine production in the US with four new pharmaceutical manufacturing sites.

Eli Lilly has announced plans to expand its domestic ... and the acquisition and expansion of a manufacturing site in Kenosha County, Wisconsin. In August 2024, the company opened the research ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday ... and the acquisition and expansion of its manufacturing site in Kenosha County, Wisconsin.